Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryLife Sciences Tools & Services
SectorN/A
SymbolNASDAQ:AFFX
CUSIP00826T10
Phone+1-408-7315000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.24%
Return on Equity4.84%
Return on Assets2.97%
Miscellaneous
EmployeesN/A
Outstanding Shares80,490,000
Affymetrix (NASDAQ:AFFX) Frequently Asked Questions
What is Affymetrix's stock symbol?
Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."
How were Affymetrix's earnings last quarter?
Affymetrix, Inc. (NASDAQ:AFFX) announced its earnings results on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 EPS for the quarter, missing the Zacks' consensus estimate of $0.11 by $0.02. The scientific and technical instruments company had revenue of $95.60 million for the quarter, compared to the consensus estimate of $93.29 million. Affymetrix had a net margin of 4.24% and a return on equity of 4.84%. During the same quarter last year, the firm posted $0.09 EPS. View Affymetrix's Earnings History.
Has Affymetrix been receiving favorable news coverage?
News headlines about AFFX stock have trended somewhat positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Affymetrix earned a media sentiment score of 0.08 on Accern's scale. They also assigned media coverage about the scientific and technical instruments company an impact score of 44.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
How do I buy shares of Affymetrix?
Shares of AFFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymetrix's stock price today?
One share of AFFX stock can currently be purchased for approximately $14.01.
How big of a company is Affymetrix?
Affymetrix has a market capitalization of $1.13 billion.
How can I contact Affymetrix?
Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.
MarketBeat Community Rating for Affymetrix (AFFX)
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe AFFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFX will underperform the S&P 500 over the long term. You may vote once every thirty days.
